Ensysce Biosciences (ENSC) Current Taxes (2017 - 2020)
Ensysce Biosciences' (ENSC) quarterly Current Taxes came in at $260404.0 in Q4 2020, down 90.6% year-over-year from $2.8 million in Q1 2020, and up 107.2% quarter-over-quarter from $125677.0 in Q3 2020.
Analysis
Ensysce Biosciences (ENSC) Current Taxes (2017 - 2020) Analysis & Trends
Ensysce Biosciences (ENSC) has reported Current Taxes for 4 consecutive years, with $260404.0 the latest figure, recorded in Q4 2020.
- On a quarterly basis, Current Taxes fell 90.6% year-over-year to $260404.0 in Q4 2020; TTM through Dec 2020 was $260404.0, a 90.6% decrease from a year earlier, with the FY2020 full-year figure at $260404.0, down 90.6% from the prior year.
- Current Taxes was $260404.0 for Q4 2020 at Ensysce Biosciences, up from $125677.0 in the prior quarter.
- Over five years, Current Taxes peaked at $2.8 million in Q4 2019 and troughed at $339.0 in Q3 2018.
- A 4-year average of $440580.4 and a median of $116750.0 in 2018 frame the typical range for Current Taxes.
- The widest YoY moves for Current Taxes: up 5245.05% in 2020, down 90.6% in 2020.
- Over 4 years, Current Taxes stood at $3635.0 in 2017, then sank by 90.67% to $339.0 in 2018, then surged by 817311.5% to $2.8 million in 2019, then slumped by 90.6% to $260404.0 in 2020.
- The last three Current Taxes figures came in at $260404.0 (Q4 2020), $125677.0 (Q3 2020), and $629914.0 (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Ensysce Biosciences | 1.18 Mn | -3.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 260,404.00 |
| Sep 30, 2020 | 125,677.00 |
| Jun 30, 2020 | 629,914.00 |
| Dec 31, 2019 | 2.77 Mn |
| Jun 30, 2019 | 11,785.00 |
| Mar 31, 2019 | 45,695.00 |
| Sep 30, 2018 | 339.00 |
| Mar 31, 2018 | 116,750.00 |
| Dec 31, 2017 | 3,635.00 |